基于 1 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Explore the full record of transactions filed by Miller Joseph M, 首席财务官. Officer active across 1 company, notably Aurinia Pharmaceuticals Inc.. In total, 10 filings have been published. Breakdown: 1 buy · 2 sells. Total volume traded: €281k. Activity tracked since 11 May 2021. The latest transaction was disclosed on 27 February 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Joseph M. Miller serves as Chief Financial Officer at Aurinia Pharmaceuticals Inc. He oversees the company's financial operations, ensuring compliance and transparency in reporting. Joseph is recognized for his expertise in financial management and his ability to support growth and innovation.